Fidaxomicin

Product Specifications

CAS Number

873857-62-6

Target

Apoptosis|||DNA/RNA Synthesis|||Antibacterial|||Antibiotic

Related Pathways

DNA Damage/DNA Repair|||Microbiology/Virology|||Apoptosis|||Cell Cycle/Checkpoint

Purity

0.9982

Bioactivity

Fidaxomicin (Tiacumicin B) is a semisynthetic macrolide antibiotic used to treat Clostridium difficile-associated diarrhea in adults. Fidaxomicin has minimal systemic absorption and has not been linked to serum enzyme elevations during therapy or to instances of clinically apparent, acute liver injury.

Smiles

[H][C@@]1(O[C@@H]2[C@@H](CC)\C=C(C)\[C@@H](O)C\C=C\C=C(CO[C@@H]3O[C@H](C)[C@@H](OC(=O)c4c(O)c(Cl)c(O)c(Cl)c4CC)[C@H](O)[C@@H]3OC)\C(=O)O[C@@]([H])(C\C=C(/C)\C=C2/C)[C@@H](C)O)OC(C)(C)[C@@H](OC(=O)C(C)C)[C@H](O)[C@@H]1O